98%
921
2 minutes
20
This manuscript consolidates 25 years of interdisciplinary research and clinical advancement in optimizing patient outcomes following osteochondral allograft (OCA) transplantation. In this manuscript, we detail the results of over 1500 OCA procedures and 115 research publications, integrating hypothesis-driven basic science and translational research with clinical outcomes data. The study highlights groundbreaking advancements, including: Innovations in fresh OCA preservation techniques that extend graft viability; Minimization of immunogenic, thermal, and impaction effects to enhance graft integration and durability; Cutting-edge methods for donor-recipient topographic matching, supported by 3D modeling; Evolution of the surgical technique, including the development of orthobiologic approaches to optimize outcomes; Evaluating long-term clinical outcomes and the effect of concomitant procedures; Decision-support algorithms that improve patient selection and surgical planning using machine learning tools. This manuscript illustrates the evolution of OCA transplantation into a reproducible, globally adopted technique for cartilage restoration. By merging basic science, translational insights, and clinical expertise, we redefine and improve the standards of graft handling, surgical technique, and clinical outcomes. The resulting data-driven guidelines and decision-support tools set a foundation for advancing the field, improving accessibility and patient selection, and enhancing patient outcomes worldwide.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jor.26089 | DOI Listing |
World J Pediatr Congenit Heart Surg
September 2025
Postgraduate Program in Health Sciences, Medical School, Federal University of Amazonas (UFAM), Manaus, Amazonas, Brazil.
To analyze in-hospital mortality in children undergoing congenital heart interventions in the only public referral center in Amazonas, North Brazil, between 2014 and 2022. This retrospective cohort study included 1041 patients undergoing cardiac interventions for congenital heart disease, of whom 135 died during hospitalization. Records were reviewed to obtain demographic, clinical, and surgical data.
View Article and Find Full Text PDFACS Sens
September 2025
METU MEMS Center, Ankara 06530, Türkiye.
Cardiovascular diseases (CVDs) remain a leading cause of death, particularly in developing countries, where their incidence continues to rise. Traditional CVD diagnostic methods are often time-consuming and inconvenient, necessitating more efficient alternatives. Rapid and accurate measurement of cardiac biomarkers released into body fluids is critical for early detection, timely intervention, and improved patient outcomes.
View Article and Find Full Text PDFClin Orthop Relat Res
September 2025
Department of Orthopedics, Division of Adult Reconstruction Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Clin Orthop Relat Res
September 2025
Leni & Peter W. May Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Background: Peripheral nerve injury commonly results in pain and long-term disability for patients. Recovery after in-continuity stretch or crush injury remains inherently unpredictable. However, surgical intervention yields the most favorable outcomes when performed shortly after injury.
View Article and Find Full Text PDFJ Alzheimers Dis
September 2025
Paula Costa-Urrutia Medical Affairs, Terumo BCT, Edificio Think MVD, Montevideo, Uruguay.
BackgroundTherapeutic plasma exchange (TPE) with albumin replacement has emerged as a potential treatment for Alzheimer's disease (AD). The AMBAR trial showed that TPE could slow cognitive and functional decline, along with changes in core and inflammatory biomarkers in cerebrospinal fluid.ObjectiveTo evaluate the safety and effectiveness of TPE in a real-world setting in Argentina.
View Article and Find Full Text PDF